A new report from AM Europe argues that Europe’s challenge in additive manufacturing is no longer only about research strength. The region already has a broad scientific base, but the next step is turning that capability into industrial use that is qualified, repeatable and commercially viable. Published in October 2026, the study maps available research competencies and points to the practical gaps that still slow wider deployment.
The report is based on an analysis of 83 research organisations across 18 countries and identifies seven major competency areas, including materials, digital technologies, testing and inspection, process qualification and industrial applications. Among the most widely represented fields, metal additive manufacturing and advanced materials appear in 66 research centres. Circularity, repair and industrial adoption are present in 65, while testing, inspection and quality assurance are found in 63.
The study also highlights cross-cutting strengths in aerospace and defence, artificial intelligence, polymers and composites, medical applications and other specialist domains. In AM Europe’s view, Europe already has many of the technical building blocks needed for broader AM uptake, especially in research centres that combine materials development, process monitoring, qualification support and shared equipment.
Those capabilities could help companies improve resource efficiency, extend component life and reinforce supply-chain resilience. Even so, the report says access remains a major issue, particularly for small and medium-sized manufacturers. Many SMEs still struggle to identify the right facilities, compare service offers and finance qualification activities. The problem is compounded by inconsistent data formats and varying testing requirements, which make research outputs harder to reuse.
AM Europe also points to long funding procedures and the absence of clear industrial ownership of demonstrators once public projects end as factors that weaken market uptake. In response, the report outlines a possible European policy agenda centred on easier access to infrastructure, shared testing resources, reusable evidence and clearer routes from research to production. Sector-focused demonstrators, stronger industry partnerships and support for trials at customer sites are presented as practical ways to build more credible business cases.
Within that framework, AM Europe positions itself as an intermediary between research organisations, companies and policymakers. The wider objective is to convert Europe’s research strengths into concrete industrial capability, with implications not only for competitiveness and sustainability, but also for defence readiness, medical innovation and a more resilient manufacturing base.
